Skip to content

Addiction: all studies

Page 524 of 857: studies 5,231 to 5,240 of 8,563, newest first. Back to the addiction overview

Research

Do dreams tell the future? Dream content as a predictor of cognitive deterioration in Parkinson’s disease

Journal of Sleep Research August 9, 2020 P. Bugalho, F. Ladeira, Raquel Barbosa et al.

Cross‐sectional studies suggest a correlation between alterations in dream content reports and executive dysfunction tests in Parkinson’s disease (PD), but this has not been assessed in longitudinal studies. Our objective was to assess the predictive value of dream content for progression of cognitive dysfunction in PD. We prospectively addressed all consecutive, non‐demented patients with PD...

Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making

August 7, 2020 Olga V. Mitina, М.а. Винникова, А. Н. Решетилов et al. preprint

## AimInvestigate accounts from breath-holding freedivers about high efficiency in coping with adversity and pain, immediately quitting addictions, attaining harmonious meaningful life, becoming perspicacious and compassionate, getting spontaneous religious experience. ## Findings Full Mystical Experience is confirmed to happen in freediving, i.e. it is the same Mystical experience found in...

Calbindin Deficits May Underlie Dissociable Effects of 5-HT6 and mGlu7 Antagonists on Glutamate and Cognition in a Dual-Hit Neurodevelopmental Model for Schizophrenia.

Molecular Neurobiology August 2020 Sinead E Shortall, Angus M Brown, Eliot Newton-Mann et al.

Despite several compounds entering clinical trials for the negative and cognitive symptoms of schizophrenia, few have progressed beyond phase III. This is partly attributed to a need for improved preclinical models, to understand disease and enable predictive evaluation of novel therapeutics. To this end, one recent approach incorporates "dual-hit" neurodevelopmental insults like neonatal...

A Review of Mediatation Enhancing the Emotional Intelligence and Subjective Well-being

International Journal of Information Technology and Management August 1, 2020 Archana Tangri Archana Tangri, Dr. Priti Dubey Dr. Priti Dubey

Meditation is a type of mental exercise that aims to increase a person's capacity for selfawareness.A new state of awareness is induced, resulting in positive outcomes for all of humanity.Focusing on a single point, such as the breath, body, or mantra, is possible. People use it for everythingfrom pain relief to stress relief to enhanced mental clarity. Having an optimistic outlook on life is a...

The impact of 3,4-methylendioxymetamphetamine (MDMA) abstinence on seeking behavior and the expression of the D2-like and mGlu5 receptors in the rat brain using saturation binding analyses.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society August 2020 Małgorzata Frankowska, Joanna Miszkiel, Lucyna Pomierny-Chamioło et al.

The abundance of research indicates that enriched environment acts as a beneficial factor reducing the risks of relapse in substance use disorder. There is also strong evidence showing the engagement of brain dopaminergic and glutamatergic signaling through the dopamine D2-like and metabotropic glutamate type 5 (mGlu5) receptors, respectively, that has a direct impact on drug reward and drug...

Progress or Pathology? Differential Diagnosis and Intervention Criteria for Meditation-Related Challenges: Perspectives From Buddhist Meditation Teachers and Practitioners

Frontiers in Psychology July 29, 2020 Jared R. Lindahl, D. James Cooper, Nathan E. Fisher et al. 2 citations

Studies in the psychology and phenomenology of religious experience have long acknowledged similarities with various forms of psychopathology. Consequently, it has been important for religious practitioners and mental health professionals to establish criteria by which religious, spiritual, or mystical experiences can be differentiated from psychopathological experiences. Many previous attempts...

DOI: 10.3389/fpsyg.2020.01905 (opens in new tab) Meditation Buddhism Intervention counseling Psychotherapist +3

The psychotherapeutic use of psychedelics

July 28, 2020 Niklas Serning, Nina Lyon 1 citation

Psychedelics are newly respectable. Evidence suggests that a variety of ills, from anxiety and depression to addictions and post-traumatic stress disorder, respond to them in a way hitherto unseen within psychiatry. The researchers involved have been careful to clean up the reputation of a class of drugs that, despite a wealth of promising evidence for their therapeutic effects in the 1960s and...

Executive Functions and Cannabis Use in Adolescents

Preprints.org July 22, 2020 Alessandro Frolli, Maria Carla Ricci, Antonella Cavallaro et al. 3 citations preprint

The developmental phase of adolescence is characterized by a multitude of neurocognitive and psychosocial changes and is therefore considered one of the most critical developmental periods of life. Experimentation on the use of substances often begins in adolescence and so does the addiction process. Most research in human subjects shows that chronic cannabis abuse is the cause of the...

The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review

Cureus July 21, 2020 Shweta Patel, Sahar Khan, M Saipavankumar et al. 69 citations

Marijuana is one of the most abused substances in the world. Marijuana is getting legalized around the world. So, it is crucial to understand its effect on our mental health. Its impact on the schizophrenia spectrum needs our special attention. Even though marijuana has been around for a long time, its exact effects are still unknown. Schizophrenia is a chronic illness affecting approximately...

Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain

Frontiers in Neuroscience July 21, 2020 Kelly F Paton, Andrew Biggerstaff, Sophia Kaska et al.

In the search for safer, non-addictive analgesics, kappa opioid receptor (KOPr) agonists are a potential target, as unlike mu-opioid analgesics, they do not have abuse potential. Salvinorin A (SalA) is a potent and selective KOPr agonist, however, clinical utility is limited by the short duration of action and aversive side effects. Biasing KOPr signaling toward G-protein activation has been...